Stay updated on Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial page.
Latest updates to the Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated to include a new type of intervention in version 2.14.0, while the previous version 2.13.3 has removed the type of intervention and a study related to Lebrikizumab.SummaryDifference0.8%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check53 days agoChange DetectedSeveral key resources and links related to genetics, eczema, and clinical trials have been removed, which may impact access to important information on these topics.SummaryDifference3%
- Check60 days agoChange DetectedThe website has been updated to version 2.12.2, adding numerous links to resources related to genetics, clinical trials, and vaccines, while removing the previous version 2.12.1.SummaryDifference3%
- Check75 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial page.